Phillips-Medisize Corporation

Phillips-Medisize, a Molex company, announced an expansion of production for a medical customer's cancer detection diagnostic kit at the Molex Little Rock facility, doubling production with new molding and automation equipment. Production is expected to begin in Q2 2018.

Phillips-Medisize, a Molex company, announced an initial investment to expand the Molex Little Rock facility to include a FDA-registered manufacturing Center of Excellence for connected health and drug delivery devices. Production is scheduled to begin in Q2 2018.

Phillips-Medisize Corporation announced plans to open a new 80,000 square foot manufacturing facility on its Menomonie, Wisconsin campus for high volume prefilled drug delivery systems, to be completed in 2017 and employing over 100 people.